Global "expiration" of abacavir in adults with HIV: a rapid review of safety and efficacy concerns challenging its role in modern ART.

Cluck DB, Chastain DB, Lines JD, Short WR, Cecchini D, Ambrosioni J, Henao-Martínez AF, Sherman EM.

Open source

DOI
10.1177/20499361251351801
Published
2025-01-01
Container
Ther Adv Infect Dis
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20499361251351801,
  title = {Global "expiration" of abacavir in adults with HIV: a rapid review of safety and efficacy concerns challenging its role in modern ART.},
  author = {Cluck DB and  Chastain DB and  Lines JD and  Short WR and  Cecchini D and  Ambrosioni J and  Henao-Martínez AF and  Sherman EM.},
  year = {2025},
  journal = {Ther Adv Infect Dis},
  doi = {10.1177/20499361251351801},
  url = {https://doi.org/10.1177/20499361251351801}
}

RIS

TY  - JOUR
TI  - Global "expiration" of abacavir in adults with HIV: a rapid review of safety and efficacy concerns challenging its role in modern ART.
AU  - Cluck DB
AU  -  Chastain DB
AU  -  Lines JD
AU  -  Short WR
AU  -  Cecchini D
AU  -  Ambrosioni J
AU  -  Henao-Martínez AF
AU  -  Sherman EM.
PY  - 2025
JO  - Ther Adv Infect Dis
DO  - 10.1177/20499361251351801
UR  - https://doi.org/10.1177/20499361251351801
ER  - 

APA

DB, C., DB, C., JD, L., WR, S., D, C., J, A., AF, H., & EM., S. (2025). Global "expiration" of abacavir in adults with HIV: a rapid review of safety and efficacy concerns challenging its role in modern ART.. Ther Adv Infect Dis. https://doi.org/10.1177/20499361251351801

Source records